Previous 10 | Next 10 |
home / stock / khrnf / khrnf news
Khiron Announces Results of 2022 Annual General and Special Meeting Canada NewsWire TORONTO , June 23, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a global leader in medical ca...
KHIRON LIFE SCIENCES ANNOUNCES CLOSING OF $4.6 MILLION OVERNIGHT BROKERED OFFERING INCLUDING FULL EXERCISE OF OVER-ALLOTMENT OPTION Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE DISSEMINATION, DISTRIBUTION, RELEASE OR PUBLI...
KHIRON LIFE SCIENCES ANNOUNCES PRICING AND SIZE OF OVERNIGHT BROKERED OFFERING Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE DISSEMINATION, DISTRIBUTION, RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN ...
KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT BROKERED OFFERING Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE DISSEMINATION, DISTRIBUTION, RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE U...
Khiron Life Sciences Corp. (KHRNF) Q1 2022 Earnings Conference Call May 31, 2022, 10:00 AM ET Company Participants Alvaro Torres - CEO and Co-Founder Franziska Katterbach - President-Europe Swapan Kakumanu - CFO Conference Call Participants Venkata Velagapudi - Research Capital Aaron Grey - A...
Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint Canada NewsWire The acquisition will accelerate Khiron's growth in Europe by controlling the complete value chain for its products and gaining di...
Khiron Life Sciences press release (OTCQX:KHRNF): Q1 GAAP EPS of -C$0.03. Revenue of C$4.6M (+64.3% Y/Y). For further details see: Khiron Life Sciences GAAP EPS of -C$0.03, revenue of C$4.6M
Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue in Medical Cannabis Canada NewsWire The Corporation recorded revenues of $4.6 million in Q1 2022, a 65% increase from Q1 2021, and a 28% increase from Q4 2021 Record revenue i...
Khiron to Host First Quarter 2022 Conference Call on May 31, 2022 Canada NewsWire TORONTO , May 25, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMXC), the global medical cannabis...
Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022 Canada NewsWire In Q1 2022, Khiron expects to surpass 1 million CAD in medical cannabis revenues in the United Kingdom ("UK") alone Total untapped potential for cannabis pati...
News, Short Squeeze, Breakout and More Instantly...
Khiron Life Sciences Corp Company Name:
KHRNF Stock Symbol:
OTCMKTS Market:
Khiron Life Sciences Corp Website:
Toronto, Ontario--(Newsfile Corp. - November 17, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (" Khiron " or the " Company ") is pleased to announce that the Company has completed the sale of its European subsidiaries, being Khiron Europe GmbH (" Khiron Europe "), Zerenia C...
Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTC Pink: KHRNF) (" Khiron " or the " Company ") today announced that the Company and 2518542 Alberta Ltd., a company controlled by Avonlea Drewry Holdings Inc. (the " Purchaser "), have entered into...
Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) (" Khiron " or the " Company ") announced today that the Company has agreed to a $500,000 non-interesting bearing refundable deposit from 2518542 Alberta Ltd. (" 251 "), a company co...